Annual Reports and Trust Strategies
Safe Staffing
From 2013 it became a national requirement for all hospitals in the UK to publish information regarding safe staffing levels on each ward every month.
The requirement was in response to the Francis Inquiry and the Berwick report which called for greater openness and transparency after the reports found that inadequate staffing levels led to the poor quality of care.
Safe Staffing reports set out the number of registered and non-registered nursing and midwifery staff working on each ward, and the percentage of shifts meeting safe staffing guidelines. Other key priorities of the reports include:
- Workforce reporting to the Trust Board
- Staffing establishment reviews
- Displaying staffing levels on noticeboards in clinical areas
- Publishing workforce data on the Trust’s website
Everyday our clinical teams review and adjust staffing levels based on acuity, dependency and clinical demands. Any concerns are escalated in a timely manner to ensure remedial actions are taken to fulfil the Trust’s strategy of putting Patients First and providing the best of care.
Below are links to some useful resources that the Trust refers to, ensuring it meets the safe staffing requirement:
Expenditure over £25k
Greater transparency over spending – as part of the Government’s drive for transparency around public spending the Medway NHS Foundation Trust is publishing details of expenditure greater than £25,000. Expenditure includes all individual invoices, grant payments, expense payments or other transactions over £25,000. There may be some occasions where transactions are not published, for example if this information might contravene the law (e.g the Data Protection Act).
Better Payment Practice Code
Pharmacy Medication Data
Published data relating to the number of patients issued medication under BNF Chapter 8 for Immune System and Malignant Disease and Chapter 10 for Musculoskeletal System.
The data in the documents below relate to the number of patients issued medication under BNF Chapter 8 for Immune System and Malignant Disease.
2023/24 – Annual Report
2022/23 – Annual Report
2021/22 – Annual Report
The data in the documents below relate to the number of patients issued medication under BNF Chapter 10 for Musculoskeletal System.
